Cargando…
Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
We describe a patient with renal magnesium wasting and prolonged, symptomatic hypomagnesemia that was refractory to oral therapies and intermittent intravenous infusion who achieved near-normal serum magnesium levels with subcutaneous magnesium infusions. A woman in her 40s was seen in nephrology cl...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024036/ https://www.ncbi.nlm.nih.gov/pubmed/36941847 http://dx.doi.org/10.1016/j.xkme.2023.100611 |
_version_ | 1784909021129474048 |
---|---|
author | Tokarski, Rebecca M. Knecht, Vincent Bezjak, Johanna D. Ray, Evan C. |
author_facet | Tokarski, Rebecca M. Knecht, Vincent Bezjak, Johanna D. Ray, Evan C. |
author_sort | Tokarski, Rebecca M. |
collection | PubMed |
description | We describe a patient with renal magnesium wasting and prolonged, symptomatic hypomagnesemia that was refractory to oral therapies and intermittent intravenous infusion who achieved near-normal serum magnesium levels with subcutaneous magnesium infusions. A woman in her 40s was seen in nephrology clinic for evaluation and management of severe, chronic hypomagnesemia because of renal magnesium wasting in combination with frequent diarrhea. Clinical manifestations associated with hypomagnesemia included muscle weakness, cognitive impairment, and frequent seizures. Her hypomagnesemia had persisted for more than 20 years despite maximal oral magnesium supplementation and frequent intravenous magnesium infusions. To provide slower delivery of parenteral magnesium, she was prescribed 2 g/d of magnesium sulfate, delivered subcutaneously. This was well tolerated, rapidly normalized her serum magnesium levels, and improved her symptoms. We briefly discuss modalities used for treatment of hypomagnesemia, including shortcomings of intravenous therapy and limited literature discussing efficacy and tolerability of subcutaneous infusions. This case report demonstrates the efficacy and safety of subcutaneous magnesium infusions in a patient with refractory hypomagnesemia and suggests that subcutaneous infusion may be safe and effective for treatment of refractory hypomagnesemia in other patients with urinary magnesium wasting. |
format | Online Article Text |
id | pubmed-10024036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-100240362023-03-19 Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report Tokarski, Rebecca M. Knecht, Vincent Bezjak, Johanna D. Ray, Evan C. Kidney Med Case Report We describe a patient with renal magnesium wasting and prolonged, symptomatic hypomagnesemia that was refractory to oral therapies and intermittent intravenous infusion who achieved near-normal serum magnesium levels with subcutaneous magnesium infusions. A woman in her 40s was seen in nephrology clinic for evaluation and management of severe, chronic hypomagnesemia because of renal magnesium wasting in combination with frequent diarrhea. Clinical manifestations associated with hypomagnesemia included muscle weakness, cognitive impairment, and frequent seizures. Her hypomagnesemia had persisted for more than 20 years despite maximal oral magnesium supplementation and frequent intravenous magnesium infusions. To provide slower delivery of parenteral magnesium, she was prescribed 2 g/d of magnesium sulfate, delivered subcutaneously. This was well tolerated, rapidly normalized her serum magnesium levels, and improved her symptoms. We briefly discuss modalities used for treatment of hypomagnesemia, including shortcomings of intravenous therapy and limited literature discussing efficacy and tolerability of subcutaneous infusions. This case report demonstrates the efficacy and safety of subcutaneous magnesium infusions in a patient with refractory hypomagnesemia and suggests that subcutaneous infusion may be safe and effective for treatment of refractory hypomagnesemia in other patients with urinary magnesium wasting. Elsevier 2023-02-07 /pmc/articles/PMC10024036/ /pubmed/36941847 http://dx.doi.org/10.1016/j.xkme.2023.100611 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Tokarski, Rebecca M. Knecht, Vincent Bezjak, Johanna D. Ray, Evan C. Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report |
title | Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report |
title_full | Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report |
title_fullStr | Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report |
title_full_unstemmed | Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report |
title_short | Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report |
title_sort | home subcutaneous magnesium infusion in refractory hypomagnesemia: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024036/ https://www.ncbi.nlm.nih.gov/pubmed/36941847 http://dx.doi.org/10.1016/j.xkme.2023.100611 |
work_keys_str_mv | AT tokarskirebeccam homesubcutaneousmagnesiuminfusioninrefractoryhypomagnesemiaacasereport AT knechtvincent homesubcutaneousmagnesiuminfusioninrefractoryhypomagnesemiaacasereport AT bezjakjohannad homesubcutaneousmagnesiuminfusioninrefractoryhypomagnesemiaacasereport AT rayevanc homesubcutaneousmagnesiuminfusioninrefractoryhypomagnesemiaacasereport |